Global Whole Genome Sequencing (WGS) Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Whole Genome Sequencing (WGS) Market Insights, Forecast to 2034
Whole-genome sequencing (WGS) is the analysis of the entire genomic DNA sequence of a cell at a single time, providing the most comprehensive characterization of the genome.
Market Analysis and InsightsGlobal Whole Genome Sequencing (WGS) Market
Global Whole Genome Sequencing (WGS) market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Whole Genome Sequencing (WGS) industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Whole Genome Sequencing (WGS) key companies include Illumina, Thermo Fisher, BGI, Agilent Technologies, 10x Genomics, QIAGEN, GENEWIZ, Macrogen and Oxford Nanopore, etc. Illumina, Thermo Fisher, BGI are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Whole Genome Sequencing (WGS) were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Whole Genome Sequencing (WGS) market and estimated to attract more attentions from industry insiders and investors.
Whole Genome Sequencing (WGS) can be divided into Large Whole-Genome Sequencing (> 5 Mb) and Small Genome Sequencing (≤ 5 Mb), etc. Large Whole-Genome Sequencing (> 5 Mb) is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Whole Genome Sequencing (WGS) is widely used in various fields, such as Humanity, Plant, Animal and Microorganism, etc. Humanity provides greatest supports to the Whole Genome Sequencing (WGS) industry development. In 2022, global % revenue of Whole Genome Sequencing (WGS) went into Humanity filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Whole Genome Sequencing (WGS) market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Whole Genome Sequencing (WGS) market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Illumina
Thermo Fisher
BGI
Agilent Technologies
10x Genomics
QIAGEN
GENEWIZ
Macrogen
Oxford Nanopore
Veritas Genetics
Centogene
Psomagen
Nebula Genomics
CD Genomics
Berry Genomics
Segment by Type
Large Whole-Genome Sequencing (> 5 Mb)
Small Genome Sequencing (≤ 5 Mb)
Humanity
Plant
Animal
Microorganism
Virus
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Whole Genome Sequencing (WGS) introduction, etc. Whole Genome Sequencing (WGS) Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Whole Genome Sequencing (WGS)
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Whole Genome Sequencing (WGS) Market
Global Whole Genome Sequencing (WGS) market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Whole Genome Sequencing (WGS) industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Whole Genome Sequencing (WGS) key companies include Illumina, Thermo Fisher, BGI, Agilent Technologies, 10x Genomics, QIAGEN, GENEWIZ, Macrogen and Oxford Nanopore, etc. Illumina, Thermo Fisher, BGI are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Whole Genome Sequencing (WGS) were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Whole Genome Sequencing (WGS) market and estimated to attract more attentions from industry insiders and investors.
Whole Genome Sequencing (WGS) can be divided into Large Whole-Genome Sequencing (> 5 Mb) and Small Genome Sequencing (≤ 5 Mb), etc. Large Whole-Genome Sequencing (> 5 Mb) is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Whole Genome Sequencing (WGS) is widely used in various fields, such as Humanity, Plant, Animal and Microorganism, etc. Humanity provides greatest supports to the Whole Genome Sequencing (WGS) industry development. In 2022, global % revenue of Whole Genome Sequencing (WGS) went into Humanity filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Whole Genome Sequencing (WGS) market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Whole Genome Sequencing (WGS) market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Illumina
Thermo Fisher
BGI
Agilent Technologies
10x Genomics
QIAGEN
GENEWIZ
Macrogen
Oxford Nanopore
Veritas Genetics
Centogene
Psomagen
Nebula Genomics
CD Genomics
Berry Genomics
Segment by Type
Large Whole-Genome Sequencing (> 5 Mb)
Small Genome Sequencing (≤ 5 Mb)
Segment by Application
Humanity
Plant
Animal
Microorganism
Virus
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Whole Genome Sequencing (WGS) introduction, etc. Whole Genome Sequencing (WGS) Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Whole Genome Sequencing (WGS)
Chapter 13Methodology and Data Sources adopted by MRAResearch